Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study

NCT07495384 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Ovarian Cancer
Platinum Resistance

Interventions

DRUG: CapsuleX

Sponsor

The First Hospital of Jilin University